109568
论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
- 3.4 Breast Cancer (Dove Med Press)
- 3.2 Clin Epidemiol
- 2.6 Cancer Manag Res
- 2.9 Infect Drug Resist
- 3.7 Clin Interv Aging
- 5.1 Drug Des Dev Ther
- 3.1 Int J Chronic Obstr
- 6.6 Int J Nanomed
- 2.6 Int J Women's Health
- 2.9 Neuropsych Dis Treat
- 2.8 OncoTargets Ther
- 2.0 Patient Prefer Adher
- 2.2 Ther Clin Risk Manag
- 2.5 J Pain Res
- 3.0 Diabet Metab Synd Ob
- 3.2 Psychol Res Behav Ma
- 3.4 Nat Sci Sleep
- 1.8 Pharmgenomics Pers Med
- 2.0 Risk Manag Healthc Policy
- 4.1 J Inflamm Res
- 2.0 Int J Gen Med
- 3.4 J Hepatocell Carcinoma
- 3.0 J Asthma Allergy
- 2.2 Clin Cosmet Investig Dermatol
- 2.4 J Multidiscip Healthc
已发表论文
高危增殖性糖尿病视网膜病变的综合管理：通过超广角成像实现精准诊断及治疗策略
Received 18 April 2025
Accepted for publication 6 September 2025
Published 12 October 2025 Volume 2025:18 Pages 3813—3832
DOI https://doi.org/10.2147/DMSO.S535338
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 4
Editor who approved publication: Prof. Dr. Ernesto Maddaloni
Zechen Liu, Jindong Han, Xiaorong Li
Tianjin Key Laboratory of Retinal Functions and Diseases, Tianjin Branch of National Clinical Research Center for Ocular Disease, Eye Institute and School of Optometry, Tianjin Medical University Eye Hospital, Tianjin, People’s Republic of China
Correspondence: Jindong Han, Tianjin Key Laboratory of Retinal Functions and Diseases, Tianjin Branch of National Clinical Research Center for Ocular Disease, Eye Institute and School of Optometry, Tianjin Medical University Eye Hospital, Tianjin, People’s Republic of China, Email djindonghan@126.com Xiaorong Li, Tianjin Key Laboratory of Retinal Functions and Diseases, Tianjin Branch of National Clinical Research Center for Ocular Disease, Eye Institute and School of Optometry, Tianjin Medical University Eye Hospital, Tianjin, People’s Republic of China, Email lixiaorong@tmu.edu.cn
Abstract: Diabetic retinopathy (DR) is a leading cause of blindness worldwide. High-risk proliferative diabetic retinopathy (HR-PDR) is an advanced stage and carries a nearly 50% risk of severe vision loss within five years without intervention. Recent advances in ultra-widefield (UWF) imaging technologies enable comprehensive detection of peripheral lesions and facilitate more accurate diagnosis of disease severity, yet standardized quantitative biomarkers for predicting disease progression remain lacking. Current treatments, including pan-retinal photocoagulation (PRP), anti-vascular endothelial growth factor (anti-VEGF) agents, and pars plana vitrectomy (PPV), demonstrate varying levels of efficacy. There is currently no consensus on the optimal treatment regimen for HR-PDR. Therefore, this review analyzes the application value of UWF imaging in HR-PDR, compares the efficacy of different treatment regimens, and considers their cost-effectiveness and practical applicability meanwhile. Using UWF color fundus photography (CFP) combined with widefield swept-source optical coherence tomography angiography (WF-SS-OCTA) may enhance diagnostic and monitoring outcomes for HR-PDR. Anti-VEGF injections followed PRP could provide stable and sustained protective effects; early PPV may improve outcomes in select cases. Future research should prioritize addressing current research gaps, including the identification of optimal anti-VEGF/PRP protocols, strategies to overcome long-term adherence challenges, establishment of consistent retreatment criteria, clarification of surgical indications, and development of socioeconomic strategies.
Keywords: high-risk proliferative diabetic retinopathy, treatment methods, diagnostic techniques, review
Tianjin Key Laboratory of Retinal Functions and Diseases, Tianjin Branch of National Clinical Research Center for Ocular Disease, Eye Institute and School of Optometry, Tianjin Medical University Eye Hospital, Tianjin, People’s Republic of China
Correspondence: Jindong Han, Tianjin Key Laboratory of Retinal Functions and Diseases, Tianjin Branch of National Clinical Research Center for Ocular Disease, Eye Institute and School of Optometry, Tianjin Medical University Eye Hospital, Tianjin, People’s Republic of China, Email djindonghan@126.com Xiaorong Li, Tianjin Key Laboratory of Retinal Functions and Diseases, Tianjin Branch of National Clinical Research Center for Ocular Disease, Eye Institute and School of Optometry, Tianjin Medical University Eye Hospital, Tianjin, People’s Republic of China, Email lixiaorong@tmu.edu.cn
Abstract: Diabetic retinopathy (DR) is a leading cause of blindness worldwide. High-risk proliferative diabetic retinopathy (HR-PDR) is an advanced stage and carries a nearly 50% risk of severe vision loss within five years without intervention. Recent advances in ultra-widefield (UWF) imaging technologies enable comprehensive detection of peripheral lesions and facilitate more accurate diagnosis of disease severity, yet standardized quantitative biomarkers for predicting disease progression remain lacking. Current treatments, including pan-retinal photocoagulation (PRP), anti-vascular endothelial growth factor (anti-VEGF) agents, and pars plana vitrectomy (PPV), demonstrate varying levels of efficacy. There is currently no consensus on the optimal treatment regimen for HR-PDR. Therefore, this review analyzes the application value of UWF imaging in HR-PDR, compares the efficacy of different treatment regimens, and considers their cost-effectiveness and practical applicability meanwhile. Using UWF color fundus photography (CFP) combined with widefield swept-source optical coherence tomography angiography (WF-SS-OCTA) may enhance diagnostic and monitoring outcomes for HR-PDR. Anti-VEGF injections followed PRP could provide stable and sustained protective effects; early PPV may improve outcomes in select cases. Future research should prioritize addressing current research gaps, including the identification of optimal anti-VEGF/PRP protocols, strategies to overcome long-term adherence challenges, establishment of consistent retreatment criteria, clarification of surgical indications, and development of socioeconomic strategies.
Keywords: high-risk proliferative diabetic retinopathy, treatment methods, diagnostic techniques, review